Access the full text.
Sign up today, get DeepDyve free for 14 days.
Mwidimi Ndosi, A. Wright-Hughes, S. Brown, M. Backhouse, Benjamin Lipsky, M. Bhogal, C. Reynolds, P. Vowden, E. Jude, J. Nixon, E. Nelson (2017)
Prognosis of the infected diabetic foot ulcer: a 12‐month prospective observational studyDiabetic Medicine, 35
R. Mathur, K. Sahu, Siddharth Saraf, Pooja Patheja, F. Khan, P. Gupta (2017)
Low-level laser therapy as an adjunct to conventional therapy in the treatment of diabetic foot ulcersLasers in Medical Science, 32
S. Sherlock (2013)
Comment on: Margolis et al. Lack of Effectiveness of Hyperbaric Oxygen Therapy for the Treatment of Diabetic Foot Ulcer and the Prevention of Amputation: A Cohort Study. Diabetes Care 2013;36:1961–1966Diabetes Care, 36
A. Boulton (2013)
The pathway to foot ulceration in diabetes.The Medical clinics of North America, 97 5
Kimberlee Hobizal, D. Wukich (2012)
Diabetic foot infections: current concept reviewDiabetic Foot & Ankle, 3
V. Driver, L. Lavery, A. Reyzelman, Tim Dutra, Cyaandi Dove, Sandra Kotsis, Hyungjin Kim, K. Chung (2015)
A clinical trial of Integra Template for diabetic foot ulcer treatmentWound Repair and Regeneration, 23
F. Gottrup, J. Apelqvist (2012)
Present and new techniques and devices in the treatment of DFU: a critical review of evidenceDiabetes/Metabolism Research and Reviews, 28
H. Gałkowska, U. Wojewódzka, W. Olszewski (2006)
Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcersWound Repair and Regeneration, 14
M. Edmonds, J. Lázaro-Martínez, Jesús Alfayate-García, J. Martini, J. Petit, G. Rayman, R. Lobmann, L. Uccioli, A. Sauvadet, S. Bohbot, J. Kerihuel, A. Piaggesi (2017)
Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial.The lancet. Diabetes & endocrinology, 6 3
S. Jeppesen, K. Yderstraede, B. Rasmussen, M. Hanna, L. Lund (2016)
Extracorporeal shockwave therapy in the treatment of chronic diabetic foot ulcers: a prospective randomised trial.Journal of wound care, 25 11
M. Edmonds, H. Bodansky, A. Boulton, P. Chadwick, C. Dang, R. D’Costa, A. Johnston, B. Kennon, G. Leese, S. Rajbhandari, T. Serena, M. Young, J. Stewart, A. Tucker, M. Carter (2018)
Multicenter, randomized controlled, observer‐blinded study of a nitric oxide generating treatment in foot ulcers of patients with diabetes—ProNOx1 studyWound Repair and Regeneration, 26
I. Goren, E. Müller, J. Pfeilschifter, S. Frank (2006)
Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-alpha.The American journal of pathology, 168 3
D. Margolis, J. Gupta, O. Hoffstad, Maryte Papdopoulos, H. Glick, S. Thom, N. Mitra (2013)
Lack of Effectiveness of Hyperbaric Oxygen Therapy for the Treatment of Diabetic Foot Ulcer and the Prevention of AmputationDiabetes Care, 36
W. Jeffcoate, F. Game, P. Cavanagh (2005)
The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetesThe Lancet, 366
R. Snyder, Matthew Cardinal, Damien Dauphinee, J. Stavosky (2010)
A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks.Ostomy/wound management, 56 3
M. Bitar (2019)
Diabetes Impairs Angiogenesis and Induces Endothelial Cell Senescence by Up-Regulating Thrombospondin-CD47-Dependent SignalingInternational Journal of Molecular Sciences, 20
C. Ottomann, A. Stojadinovic, P. Lavin, F. Gannon, M. Heggeness, R. Thiele, W. Schaden, B. Hartmann (2012)
Prospective Randomized Phase II Trial of Accelerated Reepithelialization of Superficial Second-Degree Burn Wounds Using Extracorporeal Shock Wave TherapyAnnals of Surgery, 255
G. Derosa, A. D'Angelo, C. Tinelli, E. Devangelio, A. Consoli, R. Miccoli, G. Penno, S. Prato, S. Paniga, A. Cicero (2007)
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects.Diabetes & metabolism, 33 2
C. Zelen, L. Gould, T. Serena, M. Carter, Jennifer Keller, William Li (2014)
A prospective, randomised, controlled, multi‐centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcersInternational Wound Journal, 12
L. Krokowi̇cz, J. Cwykiel, A. Klimczak, M. Mielniczuk, M. Siemionow (2010)
Pulsed acoustic cellular treatment induces expression of proangiogenic factors and chemokines in muscle flaps.The Journal of trauma, 69 6
R. Saggini, A. Figus, A. Troccola, V. Cocco, A. Saggini, N. Scuderi (2008)
Extracorporeal shock wave therapy for management of chronic ulcers in the lower extremities.Ultrasound in medicine & biology, 34 8
(2013)
Comment on: Margolis et al. Lack of Effectiveness of Hyperbaric Oxygen Therapy for the Treatment of Diabetic Foot Ulcer and the Prevention of Amputation: A Cohort Study. Diabetes Care 2013;36:1961–1966
Li Zhang, Xiao-Bing Fu, Shuo Chen, Zhanbo Zhao, C. Schmitz, Changshui Weng (2018)
Efficacy and safety of extracorporeal shock wave therapy for acute and chronic soft tissue wounds: A systematic review and meta‐analysisInternational Wound Journal, 15
Suzanne Asten, Adam Nichols, J. Fontaine, Kavita Bhavan, E. Peters, L. Lavery (2017)
The value of inflammatory markers to diagnose and monitor diabetic foot osteomyelitisInternational Wound Journal, 14
F. Game, W. Jeffcoate, L. Tarnow, J. Jacobsen, D. Whitham, E. Harrison, Sharon Ellender, D. Fitzsimmons, M. Löndahl (2018)
LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial.The lancet. Diabetes & endocrinology, 6 11
L. Lavery, J. Fulmer, K. Shebetka, M. Regulski, D. Vayser, David Fried, H. Kashefsky, T. Owings, Janaki Nadarajah (2014)
The efficacy and safety of Grafix® for the treatment of chronic diabetic foot ulcers: results of a multi‐centre, controlled, randomised, blinded, clinical trialInternational Wound Journal, 11
Khaw Kee, Harikrishna Nair, Ng Yuen (2019)
Risk factor analysis on the healing time and infection rate of diabetic foot ulcers in a referral wound care clinic.Journal of wound care, 28 Sup1
R. Ghotaslou, M. Memar, N. Alizadeh (2018)
Classification, microbiology and treatment of diabetic foot infections.Journal of wound care, 27 7
D. O'Reilly, A. Pasricha, K. Campbell, N. Burke, N. Assasi, J. Bowen, J. Tarride, R. Goeree (2013)
HYPERBARIC OXYGEN THERAPY FOR DIABETIC ULCERS: SYSTEMATIC REVIEW AND META-ANALYSISInternational Journal of Technology Assessment in Health Care, 29
W. Jeffcoate, Benjamin Lipsky, A. Berendt, P. Cavanagh, S. Bus, E. Peters, W. HOUTUM, G. Valk, K. Bakker (2008)
Unresolved issues in the management of ulcers of the foot in diabetesDiabetic Medicine, 25
Limin Jia, C. Parker, T. Parker, Ewan Kinnear, P. Derhy, Ann Alvarado, F. Huygens, P. Lazzarini (2017)
Incidence and risk factors for developing infection in patients presenting with uninfected diabetic foot ulcersPLoS ONE, 12
C. Sen, G. Gordillo, Sashwati Roy, R. Kirsner, L. Lambert, T. Hunt, F. Gottrup, G. Gurtner, M. Longaker (2009)
Human skin wounds: A major and snowballing threat to public health and the economyWound Repair and Regeneration, 17
L. Prompers, M. Huijberts, J. Apelqvist, E. Jude, A. Piaggesi, K. Bakker, M. Edmonds, P. Holstein, A. Jirkovska, D. Mauricio, G. Tennvall, H. Reike, M. Spraul, L. Uccioli, V. Urbančič, K. Acker, J. Baal, F. Merode, N. Schaper (2006)
High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale studyDiabetologia, 50
Florian Kamelger1, Markus 3, Hildegunde 3, Romed 4 (2009)
Extracorporeal Shock Wave Treatment in Ischemic Tissues: What is the Appropriate Number of Shock Wave Impulses?J Reconstr Microsurg, 26
Douglas Pacaccio, S. Cazzell, Gabriel Halperin, M. Kasper, J. Neutel, Brian O'Carroll, A. Reyzelman (2018)
Human placental membrane as a wound cover for chronic diabetic foot ulcers: a prospective, postmarket, CLOSURE study.Journal of wound care, 27 Sup7
L. Krokowi̇cz, M. Mielniczuk, M. Drews, M. Siemionow (2011)
Long-term follow up of the effects of Extracorporeal Shockwave Therapy (ESWT) on microcirculation in a denervated muscle flap.Polski przeglad chirurgiczny, 83 6
Rita Mirza, Milie Fang, Eileen Weinheimer-Haus, W. Ennis, T. Koh (2014)
Sustained Inflammasome Activity in Macrophages Impairs Wound Healing in Type 2 Diabetic Humans and MiceDiabetes, 63
C. Zelen, D. Orgill, T. Serena, R. Galiano, M. Carter, L. Didomenico, Jennifer Keller, J. Kaufman, William Li (2018)
An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow‐up trialInternational Wound Journal, 15
R. Snyder, R. Galiano, Perry Mayer, Lee Rogers, O. Alvarez (2018)
Diabetic foot ulcer treatment with focused shockwave therapy: two multicentre, prospective, controlled, double-blinded, randomised phase III clinical trials.Journal of wound care, 27 12
V. Falanga (2005)
Wound healing and its impairment in the diabetic footThe Lancet, 366
Janelle Yu, Suzanne Lu, Ann‐Marie McLaren, J. Perry, K. Cross (2016)
Topical oxygen therapy results in complete wound healing in diabetic foot ulcersWound Repair and Regeneration, 24
R. Frykberg, G. Gibbons, Jodi Walters, D. Wukich, Farrell Milstein (2016)
A prospective, multicentre, open‐label, single‐arm clinical trial for treatment of chronic complex diabetic foot wounds with exposed tendon and/or bone: positive clinical outcomes of viable cryopreserved human placental membraneInternational Wound Journal, 14
K. Pickwell, V. Siersma, M. Kars, J. Apelqvist, K. Bakker, M. Edmonds, P. Holstein, A. Jirkovska, E. Jude, D. Mauricio, A. Piaggesi, G. Tennvall, H. Reike, M. Spraul, L. Uccioli, V. Urbančič, K. Acker, J. Baal, N. Schaper (2015)
Predictors of Lower-Extremity Amputation in Patients With an Infected Diabetic Foot UlcerDiabetes Care, 38
S. Wanner, M. Gstöttner, R. Meirer, J. Hausdorfer, M. Fille, B. Stöckl (2011)
Low-energy shock waves enhance the susceptibility of staphylococcal biofilms to antimicrobial agents in vitro.The Journal of bone and joint surgery. British volume, 93 6
R. Nunan, K. Harding, Paul Martin (2014)
Clinical challenges of chronic wounds: searching for an optimal animal model to recapitulate their complexityDisease Models & Mechanisms, 7
B. Moretti, A. Notarnicola, G. Maggio, L. Moretti, M. Pascone, S. Tafuri, V. Patella (2009)
The management of neuropathic ulcers of the foot in diabetes by shock wave therapyBMC Musculoskeletal Disorders, 10
G. Huemer, R. Meirer, R. Gurunluoglu, F. Kamelger, K. Dunst, S. Wanner, H. Piza-Katzer (2005)
Comparison of the effectiveness of gene therapy with transforming growth factor‐β or extracorporal shock wave therapy to reduce ischemic necrosis in an epigastric skin flap model in ratsWound Repair and Regeneration, 13
R. Frykberg, Jaminelli Banks (2015)
Challenges in the Treatment of Chronic WoundsAdvances in Wound Care, 4
Objective:The objective of this paper is to present the secondary safety and efficacy outcomes from two studies of focused extracorporeal shockwave therapy (ESWT) used adjunctively with standard care in the treatment of neuropathic diabetic foot ulcers (DFU) (1A or 2A on the University of Texas grading scheme), compared with sham treatment and standard care.Method:We carried out two multicentre, multinational, randomised, sham-controlled, double-blinded, phase III clinical studies using standard care with adjunctive focused ESWT compared with sham treatment and standard care in patients with a DFU. DFUs that did not reduce in volume by at least 50% over two weeks' standard treatment were included. DFUs were randomised and managed with standard care and focused ESWT (pulsed acoustic cellular expression; dermaPACE System, SANUWAVE Health, Inc.) active therapy, or with standard care and sham treatment, four times over a two-week treatment phase in study 1 and up to eight times over 12 weeks in study 2. Standard care continued in both studies throughout the 12-week treatment phase. Secondary outcomes were indicators of wound closure and progression, pain, infection, amputation and recurrence, and device reliability. Efficacy-related secondary endpoints were measured at 12, 20 and 24 weeks. The studies were analysed separately and following statistical comparison to justify the method, as a pooled data set.Results:Wound area reduction (48.6% versus 10.7%, p=0.015, intention to treat (ITT) population with last observation carried forward (LOCF)) and perimeter reduction (46.4% versus 25.0%, p=0.022, ITT population with LOCF) were significantly greater in the active therapy group compared with the sham-treated group, respectively. The difference in time to wound closure in the pooled ITT population was significantly in favour of the active therapy group (84 days versus 112 days for 25% of subjects to reach wound closure in the active and sham-treated groups, respectively; p=0.0346). The proportion of subjects who achieved wound area reduction (WAR) from baseline at week 12 of ≥90% was significantly higher in the active therapy group. The incidence and nature of infection were consistent with previously published studies, and pain was not increased in the active therapy group. Amputation was insignificantly higher in the sham-treated group and recurrence did not differ. The ESWT device was found to be reliable.Conclusion:The outcomes for the primary and secondary endpoints from these studies show that ESWT administered adjunctively with standard care is an effective advanced therapy for neuropathic DFUs (grade 1A and 2A) that do not respond to two weeks' standard care alone by reducing wound volume by at least 50%.
Journal of Wound Care – Mark Allen Group
Published: Jun 2, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.